Clinical Trials List
2013-12-23 - 2021-08-12
Phase I/II
Terminated7
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 林育麟 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- Chong-Jen Yu Division of General Internal Medicine
- 廖唯昱 Division of General Internal Medicine
- JIN-YUAN SHIH Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 陳冠宇 Division of General Internal Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- JENG-SEN TSENG Division of Thoracic Medicine
- TSUNG -YING YANG Division of Thoracic Medicine
- 陳焜結 Division of Thoracic Medicine
- KUO-HSUAN HSU Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Chao-Hua Chiu Division of Thoracic Medicine
- Jen-Fu Shih Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 廖偉志 Division of Thoracic Medicine
- Chih-Yen Tu Division of Thoracic Medicine
- 陳鴻仁 Division of Thoracic Medicine
- Chen Chia-Hung Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Shih-Hong Li Division of Hematology & Oncology
- 黃世豪 Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- 李忠恕 Division of Infectious Disease
- 謝任富 Division of Radiology
- Chih-Hung Chen Division of Hematology & Oncology
- 林倡葦 Division of Infectious Disease
- Chih-Liang Wang Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 王逸熙 Division of Thoracic Medicine
- 陳友木 Division of Thoracic Medicine
- 饒坤銘 Division of Hematology & Oncology
- 方文豐 Division of Thoracic Medicine
- 高旭卿 Division of Thoracic Medicine
- 張晃智 Division of Thoracic Medicine
- 李易濰 Division of Radiology
- 陳彥豪 Division of Hematology & Oncology
- 蘇茂昌 Division of Thoracic Medicine
- Chia-Cheng Tseng Division of Thoracic Medicine
- 鍾聿修 Division of Thoracic Medicine
- Shau-Hsuan Li Division of Hematology & Oncology
- 陳永哲 Division of Thoracic Medicine
- 林孟志 Division of Thoracic Medicine
- 賴建豪 Division of Thoracic Medicine
- 趙東瀛 Division of Thoracic Medicine
- 黃國棟 Division of Thoracic Medicine
- 秦建弘 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2/8 participants
-
Global
18/70 participants
